Medians Pharma Private Limited

Markets pharmaceutical and medical products such as capsules, tablets, and syrup.

2016 | Aurangabad, Maharashtra (India) | Active
Last Updated:

Medians Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth 81.45%
  • Ebitda 86.14%
  • Net Worth -0.90%
  • Total Assets -3.42%

About Medians Pharma

Medians Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2016 (Nine years and two months 26 days old ). Its registered office is in Aurangabad, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Mangesh Gaikwad, Nikhil Jadhav, Sushil Marathe, and One other member serve as directors at the Company.

Company Details

  • Location

    Aurangabad, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74120MH2016PTC273089

  • Company No.

    273089

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Feb 2016

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Medians Pharma Private Limited

Explore comprehensive data for Medians Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Medians Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Mangesh Gaikwad Country flag representing In Director 12-Feb-2016Current
Nikhil Jadhav Country flag representing In Director 12-Feb-2016Current
Sushil Marathe Country flag representing In Director 12-Feb-2016Current
Prashant Patil Country flag representing In Director 01-Jan-2018Current

Financial Performance of Medians Pharma.

Medians Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 81.45% increase in profit. The company's net worth dipped by a decrease of 0.9%.

Medians Pharma revenue growth over time
Medians Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-3.42%
Profit or Loss
81.45%
Net Worth
-0.90%
EBITDA
86.14%

What is the Ownership and Shareholding Structure of Medians Pharma?

In 2019, Medians Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Medians Pharma?

Unlock and access historical data on people associated with Medians Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Medians Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medians Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medians Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Medians Pharma

Recent activity within the organization

  • Annual General Meeting

    Medians Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Medians Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Prashant Kautik Patil was appointed as a Director was appointed as a Director on 01 Jan 2018 & has been associated with this company since 7 years 4 months .

  • Director Appointment

    Mangesh Sambhaji Gaikwad was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 2 months .

  • Director Appointment

    Nikhil Dasharath Jadhav was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 2 months .

  • Director Appointment

    Sushil Kiran Marathe was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Medians Pharma Private Limited?

    Medians Pharma Private Limited was incorporated on 12 Feb 2016.

  • What is authorized share capital and paid-up capital of Medians Pharma Private Limited?

    The authorized share capital of Medians Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Medians Pharma Private Limited?

    Currently 4 directors are associated with Medians Pharma Private Limited.

    • Mangesh Sambhaji Gaikwad
    • Nikhil Dasharath Jadhav
    • Sushil Kiran Marathe
    • Prashant Kautik Patil
  • What is the registered address of Medians Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Medians Pharma Private Limited is Flat No. 303 Plot 5 Gug- Apartment Sakshi Pride India, Aurangabad, Maharashtra, 431005.

  • What is the corporate identification number (CIN) and company number of Medians Pharma Private Limited?

    The corporate identification number (CIN) of Medians Pharma Private Limited is U74120MH2016PTC273089 and the company number is 273089 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Medians Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Medians Pharma Private Limited has experienced an downturn of -0.90%.

  • When was the last Balance Sheet of Medians Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Medians Pharma Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial